INSTITUTION'S PROFILE
Statistical Centre for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Publications (1)
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Journal: Lancet (London, England)
Publication date: 2022
Journal: Lancet (London, England)
Publication Year: 2022